People take medication because it is necessary to cure or manage an illness. What happens when the medication has an unintended consequence?
Viona Pharmaceuticals, a New Jersey based pharmaceutical company is recalling all 33 lots of its type 2 diabetes drug 750 mg strength metformin. This product is used to improve blood glucose control in adults with type 2 diabetes mellitus. The recall has occurred after long-term testing revealed too much NDMA, which is classified as a probable human carcinogen and was the reason for numerous metformin recalls in 2020. Specifically, this is a substance that could result in cancer.
Lots being recalled include, but are not limited to:
Nos. M008130-133, exp. date 06/2022; M010080-81, exp. 07/2022; M011029-32, exp. 08/2022; M013394-96, M013966-67, exp. 09/2022; M100831-32, exp. 12/2022; M100833-34, M101267, M102718-20, exp. 01/2023; M102721-22, M104172-76, exp. 02/2023; M105889-90, exp. 03/2023.
The attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully represented consumers in similar matters. If you have purchased or know someone who has purchased Viona Pharmaceutical’s Metformin Hydrochloride Extended-Release Tablets and were harmed by the product, contact us to discuss your legal options.